Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
在既往接受过治疗的多发性骨髓瘤患者中，塞利尼索、硼替佐米和地塞米松联合治疗与硼替佐米和地塞米松单药治疗的疗效比较：按细胞遗传学风险分层分析。
期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.26261
Richard, Shambavi; Chari, Ajai; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Kriachok, Iryna; Dimopoulos, Meletios A; Pylypenko, Halyna; Auner, Holger W; Leleu, Xavier; Usenko, Ganna; Hajek, Roman; Benjamin, Reuben; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Christopher P; Garg, Mamta; Stevens, Don Ambrose; Quach, Hang; Jagannath, Sundar; Moreau, Phillipe; Levy, Moshe; Badros, Ashraf; Anderson, Larry D Jr; Bahlis, Nizar J; Facon, Thierry; Mateos, Maria Victoria; Cavo, Michele; Chang, Hua; Landesman, Yosef; Chai, Yi; Arazy, Melina; Shah, Jatin; Shacham, Sharon; Kauffman, Michael G; Grosicki, Sebastian; Richardson, Paul G
